Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OPB-51602 in Advanced Solid Tumors and Nasopharyngeal Carcinoma
NCT02058017Phase 1Terminated
- Sponsor
- National University Hospital
- Start
- Nov 2013
- Primary completion
- May 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of opb-51602 in solid tumor and nasopharyngeal carcinoma (NPC), sponsored by National University Hospital. Started Nov 2013; status: terminated.
02
Drugs
opb-51602
03
Conditions
solid tumornasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT02058017.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02058017.